Trial Profile
A national ,multicenter,cohort study comparing efficacy of Ledipasvir/Sofosbuvir in monoinfected Hepatitis C virus infected patients with HIV co-infected treatment naive Hepatitis C virus infected patients: Data from German Hepatitis C-registry (DHC-R)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 08 Feb 2017 New trial record